Journal of Hepatology / Aug 01, 2017

Shirvani-Dastgerdi, E., Winer, B. Y., Celià-Terrassa, T., Kang, Y., Tabernero, D., Yagmur, E., Rodríguez-Frías, F., Gregori, J., Luedde, T., Trautwein, C., Ploss, A., & Tacke, F. (2017). Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy. Journal of Hepatology, 67(2), 246–254. https://doi.org/10.1016/j.jhep.2017.03.027

Current Opinion in Virology / Oct 01, 2016

Shirvani-Dastgerdi, E., Schwartz, R. E., & Ploss, A. (2016). Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology, 20, 1–10. https://doi.org/10.1016/j.coviro.2016.07.009

Scientific Reports / Apr 29, 2016

Riemenschneider, M., Cashin, K. Y., Budeus, B., Sierra, S., Shirvani-Dastgerdi, E., Bayanolhagh, S., Kaiser, R., Gorry, P. R., & Heider, D. (2016). Genotypic Prediction of Co-receptor Tropism of HIV-1 Subtypes A and C. Scientific Reports, 6(1). https://doi.org/10.1038/srep24883

Science Translational Medicine / Jun 27, 2018

Winer, B. Y., Shirvani-Dastgerdi, E., Bram, Y., Sellau, J., Low, B. E., Johnson, H., Huang, T., Hrebikova, G., Heller, B., Sharon, Y., Giersch, K., Gerges, S., Seneca, K., Pais, M.-A., Frankel, A. S., Chiriboga, L., Cullen, J., Nahass, R. G., Lutgehetmann, M., … Ploss, A. (2018). Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Science Translational Medicine, 10(447). https://doi.org/10.1126/scitranslmed.aap9328

World Journal of Virology / Jan 01, 2012

Dastgerdi, E. S. (2012). Molecular and clinical aspects of hepatitis D virus infections. World Journal of Virology, 1(3), 71. https://doi.org/10.5501/wjv.v1.i3.71

World Journal of Virology / Jan 01, 2015

Shirvani-Dastgerdi, E. (2015). Molecular interactions between hepatitis B virus and delta virus. World Journal of Virology, 4(2), 36. https://doi.org/10.5501/wjv.v4.i2.36

Journal of Medical Virology / Aug 01, 2016

Sadeghi, A., Shirvani‐Dastgerdi, E., Tacke, F., Yagmur, E., Poortahmasebi, V., Poorebrahim, M., Mohraz, M., Hajabdolbaghi, M., Rasoolinejad, M., Abbasian, L., Jafari, R., Fakhari, Z., Norouzi, M., Ebrahimian, A., Geravand, B., Alavian, S. M., & Jazayeri, S. M. (2016). HBsAg mutations related to occult hepatitis B virus infection in HIV‐positive patients result in a reduced secretion and conformational changes of HBsAg. Journal of Medical Virology, 89(2), 246–256. Portico. https://doi.org/10.1002/jmv.24623

Clinical Microbiology and Infection / May 01, 2015

Shirvani-Dastgerdi, E., Amini-Bavil-Olyaee, S., Alavian, S. M., Trautwein, C., & Tacke, F. (2015). Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression. Clinical Microbiology and Infection, 21(5), 510.e11-510.e23. https://doi.org/10.1016/j.cmi.2014.12.008

Zahedan Journal of Research in Medical Sciences / Apr 30, 2018

Valavi, E., Aminzadeh, M., Shirvani, E., Jaafari, L., & Madhooshi, S. (2018). The Main Causes of Mortality in Pediatric Intensive Care Unit in South West of Iran. Zahedan Journal of Research in Medical Sciences, 20(4). https://doi.org/10.5812/zjrms.63006

NanoEthics / Aug 02, 2012

Rahimpour, M., Rahimpour, M., Gomari, H., Shirvani, E., Niroumanesh, A., Saremi, K., & Sardari, S. (2012). Public Perceptions of Nanotechnology: A Survey in the Mega Cities of Iran. NanoEthics, 6(2), 119–126. https://doi.org/10.1007/s11569-012-0147-1

Infection, Genetics and Evolution / Apr 01, 2017

Mina, T., Amini-Bavil-Olyaee, S., Shirvani-Dastgerdi, E., Trovão, N. S., Van Ranst, M., & Pourkarim, M. R. (2017). 15 year fulminant hepatitis B follow-up in Belgium: Viral evolution and signature of demographic change. Infection, Genetics and Evolution, 49, 221–225. https://doi.org/10.1016/j.meegid.2017.01.020

Clinical Microbiology and Infection / Jan 01, 2016

Shirvani-Dastgerdi, E., Pourkarim, M. R., Herbers, U., Amini-Bavil-Olyaee, S., Yagmur, E., Alavian, S. M., Trautwein, C., & Tacke, F. (2016). Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro. Clinical Microbiology and Infection, 22(1), 98.e1-98.e6. https://doi.org/10.1016/j.cmi.2015.09.020

Hepatitis Monthly / Jun 01, 2012

Tacke, F., & Shirvani-Dastgerdi, E. (2012). Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro. Hepatitis Monthly, 12(6), 357–360. https://doi.org/10.5812/hepatmon.6131

Hepatitis Monthly / Sep 30, 2011

Dastgerdi, E. S., & Amini-Bavil-Olyaee, S. (2011). Hepatitis E Virus Infection in Macaca Mulatta. Hepatitis Monthly, 11(10), 852–853. https://doi.org/10.5812/kowsar.1735143x.783

mBio / Jul 12, 2023

Maya, S., Hershkovich, L., Cardozo-Ojeda, E. F., Shirvani-Dastgerdi, E., Srinivas, J., Shekhtman, L., Uprichard, S. L., Berneshawi, A. R., Cafiero, T. R., Dahari, H., & Ploss, A. (2023). Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic. MBio. https://doi.org/10.1128/mbio.01008-23

Feb 17, 2023

Maya, S., Hershkovich, L., Cardozo-Ojeda, E. F., Shirvani-Dastgerdi, E., Srinivas, J., Shekhtman, L., Uprichard, S. L., Berneshawi, A. R., Cafiero, T. R., Dahari, H., & Ploss, A. (2023). Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic. https://doi.org/10.1101/2023.02.17.528964

Hepatitis Delta Virus / Jan 01, 2006

Sureau, C. (2006). Hepatitis Delta Virus: HDV-HBV Interactions. In Hepatitis Delta Virus (pp. 10–19). Springer US. https://doi.org/10.1007/0-387-35103-5_2

BMC Gastroenterology / Feb 05, 2015

Morawska, M. (2015). BMC Gastroenterology reviewer acknowledgement 2014. BMC Gastroenterology, 15(1). https://doi.org/10.1186/s12876-015-0238-x